Clinical Trial Update: Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL

View source ↗

Summary

A terminated clinical trial comparing the pharmacokinetic profile of vincristine when given with imatinib in BCR-ABL positive acute lymphoblastic leukemia to vi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Vincristine (vincristine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Acute Lymphoblastic Leukemia | Status: TERMINATED